摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-bromophenyl)-2-(naphthalen-1-yloxy)ethanone

中文名称
——
中文别名
——
英文名称
1-(4-bromophenyl)-2-(naphthalen-1-yloxy)ethanone
英文别名
α-(α-naphthyloxy)-4-bromoacetophenone;1-(4-Bromophenyl)-2-naphthalen-1-yloxyethanone
1-(4-bromophenyl)-2-(naphthalen-1-yloxy)ethanone化学式
CAS
——
化学式
C18H13BrO2
mdl
——
分子量
341.204
InChiKey
BSZVCDXJIAYDDD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    SCHERRER, R. A.;STERN, R. M.
    摘要:
    DOI:
  • 作为产物:
    描述:
    萘酚2,4'-二溴苯乙酮potassium carbonate 、 potassium iodide 作用下, 以 丙酮 为溶剂, 反应 3.5h, 生成 1-(4-bromophenyl)-2-(naphthalen-1-yloxy)ethanone
    参考文献:
    名称:
    一系列新型抗寄生虫芳氧基硫代半碳唑酮抑制克氏锥虫的合成及构效关系研究
    摘要:
    有必要发现一种新的抗查加斯锥虫病的病原体克氏锥虫的抗寄生虫化合物。新颖的芳氧基芳基缩氨基硫脲基构象受限缩氨基硫脲(类似物/ 1)和(2)被开发作为潜在抑制剂的锥虫蛋白酶cruzain,使用的(在iminic键的硬化策略1)和(2)。结构-活性关系分析是在芳基和芳氧基环上连接的取代基上进行的。这项研究表明,与未取代的硫代半脲相比,芳基位置的非极性取代基或卤素原子取代改善了Cruzain的抑制作用和抗寄生虫活性。这些化合物中的两种通过抑制Cruzain表现出有效的抑制性抗寄生虫活性,因此能够减少感染细胞中的寄生虫负担,并通过坏死导致寄生虫细胞死亡。总之,我们证明了构象限制是开发抗寄生虫硫代氨基脲的有价值的策略。
    DOI:
    10.1016/j.ejmech.2015.06.048
点击查看最新优质反应信息

文献信息

  • Synthesis and structure–activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain
    作者:José Wanderlan Pontes Espíndola、Marcos Veríssimo de Oliveira Cardoso、Gevanio Bezerra de Oliveira Filho、Dayane Albuquerque Oliveira e Silva、Diogo Rodrigo Magalhaes Moreira、Tanira Matutino Bastos、Carlos Alberto de Simone、Milena Botelho Pereira Soares、Filipe Silva Villela、Rafaela Salgado Ferreira、Maria Carolina Accioly Brelaz de Castro、Valéria Rego Alves Pereira、Silvane Maria Fonseca Murta、Policarpo Ademar Sales Junior、Alvaro José Romanha、Ana Cristina Lima Leite
    DOI:10.1016/j.ejmech.2015.06.048
    日期:2015.8
    thiosemicarbazone-based conformationally constrained analogs of thiosemicarbazones (1) and (2) were developed as potential inhibitors of the T. cruzi protease cruzain, using a rigidification strategy of the iminic bond of (1) and (2). A structure–activity relationship analysis was performed in substituents attached in both aryl and aryloxy rings. This study indicated that apolar substituents or halogen atom substitution
    有必要发现一种新的抗查加斯锥虫病的病原体克氏锥虫的抗寄生虫化合物。新颖的芳氧基芳基缩氨基硫脲基构象受限缩氨基硫脲(类似物/ 1)和(2)被开发作为潜在抑制剂的锥虫蛋白酶cruzain,使用的(在iminic键的硬化策略1)和(2)。结构-活性关系分析是在芳基和芳氧基环上连接的取代基上进行的。这项研究表明,与未取代的硫代半脲相比,芳基位置的非极性取代基或卤素原子取代改善了Cruzain的抑制作用和抗寄生虫活性。这些化合物中的两种通过抑制Cruzain表现出有效的抑制性抗寄生虫活性,因此能够减少感染细胞中的寄生虫负担,并通过坏死导致寄生虫细胞死亡。总之,我们证明了构象限制是开发抗寄生虫硫代氨基脲的有价值的策略。
  • Certain substituted 2-phenylnaphtho[1,2-b]furane and -[2,1-b]furane
    申请人:Sterling Drug Inc.
    公开号:US04111962A1
    公开(公告)日:1978-09-05
    2-Phenylnaphtho[1,2-b]furan, 2-phenylnaphtho[2,1-b]-furan and derivatives thereof substituted in the phenyl ring by alkyl, halo or cyano are useful as antifertility agents, and are prepared by cyclization of a naphthyloxyacetophenone with a strong acid.
    2-苯基萘并[1,2-b]呋喃,2-苯基萘并[2,1-b]-呋喃及其苯环上取代为烷基、卤素或氰基的衍生物可用作抗生育剂,并通过将萘氧基乙酮与强酸进行环化反应制备。
  • SCHERRER, R. A.;STERN, R. M.
    作者:SCHERRER, R. A.、STERN, R. M.
    DOI:——
    日期:——
  • US4111962A
    申请人:——
    公开号:US4111962A
    公开(公告)日:1978-09-05
  • Discovery of oxime-bearing naphthalene derivatives as a novel structural type of Nrf2 activators
    作者:Ken-Ming Chang、Fong-Pin Liang、I-Li Chen、Shyh-Chyun Yang、Shin-Hun Juang、Tai-Chi Wang、Yeh-Long Chen、Cherng-Chyi Tzeng
    DOI:10.1016/j.bmc.2015.03.046
    日期:2015.7
    Recent studies have demonstrated that oxidative stress insult is one of major causes of tumor formation. Therefore, identify the effective anti-oxidative agents as a preventive approach to stop cancer progression has widely explored. Although, many potent anti-oxidative ingredients in the natural products have been identified but the amount from the nature source hindrances the clinical application. Compound which can activate Nrf2 signaling pathway result unregulated the cellular antioxidant-responses has been demonstrated as an effective chemopreventive approach for cancer treatment. In the present study, certain oxime-bearing naphthalene derivatives were synthesized and evaluated for their Nrf2 activation and anti-proliferative activities. Results indicated (E)-1-(naphthalen-2-yloxy) propan-2-one oxime (11) which increased 2.04-fold Nrf2/ARE-driven luciferase activity was more active than its 1-substituted isomer 10 (1.17-fold) and t-BHQ (1.77-fold), the known Nrf2 activator. The activities were further increased by the replacement of the peripheral methyl group with the phenyl ring in which (Z)-2-(naphthalen-2-yloxy)-1-phenylethanone oxime (13a) exhibited 3.49-fold potency of the positive control. It is worth to mention that compounds 11, 13a, and 13b which showed significant Nrf2 activation are non-cytotoxic to the tested cells with IC50 > 50 mu M. This observation strongly suggested that these compounds can be used for chemoprevention. Mechanism studies indicated that these compounds were capable of inducing the phosphorylation of Nrf2 protein at serine 40 which led to the activation of the Nrf2 transcriptional activity. (C) 2015 Elsevier Ltd. All rights reserved.
查看更多